InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
5
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Klemp Walter V, Chairman & CEO. Officer active across 2 companies, notably Moleculin Biotech, Inc.. Cumulatively, 28 disclosures have been published. Breakdown: 5 buys · 0 sell. Total volume traded: €278k. History available since 16 December 2021. The latest transaction was disclosed on 26 December 2023 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Klemp Walter V
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations28 total
533,333 sharesCommon StockSEC:0001437749-26-025928:0
Canonical exit: 1 Nov 2026 (T+90)
150 sharesCommon StockSEC:0001437749-26-021611:0
37 sharesCommon StockSEC:0001437749-26-021611:1
360 sharesCommon StockSEC:0001437749-26-021611:2
88 sharesCommon StockSEC:0001437749-26-021611:3
28,750 sharesCommon StockSEC:0001437749-25-033683:0
3,750 sharesCommon StockSEC:0001437749-25-021050:0
1,667 sharesCommon StockSEC:0001437749-25-020802:0
982 sharesCommon StockSEC:0001437749-24-022252:0
8,990 sharesCommon StockSEC:0001437749-24-021197:0
3,750 sharesCommon StockSEC:0001437749-24-020995:0
1,667 sharesCommon StockSEC:0001437749-24-020663:0
188,404 shares@ US$0.6942.4% of flowCommon StockSEC:0001437749-23-035340:0
Canonical exit: 25 Mar 2024 (T+90)
13,204 sharesCommon StockSEC:0001437749-23-019907:0
14,717 sharesCommon StockSEC:0001437749-23-019412:0
56,250 sharesCommon StockSEC:0001437749-23-018140:0
25,000 sharesCommon StockSEC:0001437749-23-017884:0
45,000 shares@ US$1.280719.9% of flowCommon StockSEC:0001437749-22-028116:0
Canonical exit: 23 Feb 2023 (T+90)
22,500 shares@ US$1.14969.0% of flowCommon StockSEC:0001437749-22-027949:0
Canonical exit: 19 Feb 2023 (T+90)
85,213 shares@ US$0.969528.7% of flowCommon StockSEC:0001437749-22-027792:0
Canonical exit: 14 Feb 2023 (T+90)
14,717 sharesCommon StockSEC:0001437749-22-017220:0
13,204 sharesCommon StockSEC:0001437749-22-017219:0
13,204 sharesCommon StockSEC:0001437749-22-017075:0
14,717 sharesCommon StockSEC:0001437749-22-016754:0
25,000 sharesCommon StockSEC:0001437749-22-015536:0
25 of 28 declarations
About Klemp Walter V
KLEMP WALTER V is Président-Directeur Général. He is linked to Moleculin Biotech, Inc., where he is CEO and President, and to Soliton, Inc., where he is Executive Chairman. He has made 27 filings in total, and, across the recent sampled filings held, buy amounts are 278132 EUR and sell amounts are 8506957 EUR, with filings ranging from 2021-07-06 to 2026-06-24.
